Mereo BioPharma Group plc (MPH.L) (LON:MPH) Trading Down 1.9%

Mereo BioPharma Group plc (MPH.L) (LON:MPHGet Free Report)’s stock price fell 1.9% during trading on Wednesday . The stock traded as low as GBX 26 ($0.32) and last traded at GBX 26.50 ($0.33). 49,264 shares were traded during trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.33).

Mereo BioPharma Group plc (MPH.L) Price Performance

The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26. The stock has a market capitalization of £89.76 million and a price-to-earnings ratio of -0.21. The company’s 50 day moving average is GBX 26.50 and its 200 day moving average is GBX 26.50.

About Mereo BioPharma Group plc (MPH.L)

(Get Free Report)

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.

Featured Stories

Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with's FREE daily email newsletter.